P27 JUMC
From LipidomicsWiki
(Difference between revisions)
Line 6: | Line 6: | ||
|myAbout= | |myAbout= | ||
|myContribution=The Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue. | |myContribution=The Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue. | ||
- | |myTaskforces= | + | |myTaskforces=[[TASK_FORCE_II|TASK_FORCE_II]], [[TASK_FORCE_IV|TASK_FORCE_IV]], [[TASK_FORCE_IVI|TASK_FORCE_IVI]], and [[TASK_FORCE_IVIX|TASK_FORCE_IVIX]] |
- | |myWorkpackages= | + | |myWorkpackages=[[WP4|WP4]] and [[WP8|WP8]] |
}}<br> <br> | }}<br> <br> | ||
[[Category:Project_organisation]] | [[Category:Project_organisation]] |
Revision as of 06:59, 16 June 2011
Institution | Jagiellonian University Medical College - Prof. Aldona Dembinska-Kieć MD PhD | |
Principal investigator | {{{myPrincipal_investigator}}} | |
Country | Poland | |
Beneficiary Number | P09 | |
About us | ||
Contributions | The Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue. | |
Member of Taskforces | TASK_FORCE_II, TASK_FORCE_IV, TASK_FORCE_IVI, and TASK_FORCE_IVIX | |
Member of Workpackages | WP4 and WP8 |